论文部分内容阅读
目的分析厄贝沙坦氢氯噻嗪片联合护理对高血压并糖尿病临床效果影响。方法选取2014年2月~2016年2月收治的98例高血压并糖尿病患者临床资料,分为对照组(49例)、观察组(49例),对照组采用厄贝沙坦治疗,观察组给予厄贝沙坦氢氯噻嗪片口服结合护理干预,观察比较两组临床效果及生活质量情况。结果两组治疗后FPG、2h PG、SBP、DBP指标均较护理前下降,其中,对照组下降程度明显小于观察者组(P<0.05);对照组GQOL-74各项指标评分均较观察组低(P<0.05)。结论对高血压并糖尿病患者采用厄贝沙坦氢氯噻嗪片治疗结合护理干预能快速降低患者血压、血糖指标,提高其生活质量。
Objective To analyze the clinical effect of irbesartan combined with hydrochlorothiazide in the treatment of hypertension and diabetes mellitus. Methods The clinical data of 98 patients with hypertension and diabetes mellitus admitted from February 2014 to February 2016 were divided into control group (49 cases) and observation group (49 cases), the control group was treated with irbesartan, the observation group Give irbesartan Hydrochlorothiazide tablets combined oral nursing intervention, observed and compared the clinical effect and quality of life of the two groups. Results The levels of FPG, 2h PG, SBP and DBP in both groups decreased after treatment compared with that before treatment, and the decrease in the control group was significantly less than that in the observer group (P <0.05). The scores of GQOL-74 in the control group were significantly lower than those in the observation group Low (P <0.05). Conclusion Treatment of hypertension and diabetes mellitus with irbesartan hydrochlorothiazide tablets combined with nursing intervention can quickly reduce blood pressure and blood glucose in patients with elevated quality of life.